Evidence map›Paper›PMID 37598704›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2023

Modernizing the design and analysis of prevalence surveys for neglected tropical diseases.

Peter J Diggle, Claudio Fronterre, Katherine Gass, Lee Hundley, Reza Niles-Robin, Annastacia Sampson, Ana Morice, Ronaldo Carvalho Scholte

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peter J DiggleCHICAS, Lancaster Medical School, Lancaster University, Lancaster, LA1 3YF, UK.ORCID 0000-0003-3521-5020
Claudio FronterreCHICAS, Lancaster Medical School, Lancaster University, Lancaster, LA1 3YF, UK.
Katherine GassTask Force for Global Health, 325 Swanton Way, Decatur, 30030, GA, USA.
Lee HundleyTask Force for Global Health, 325 Swanton Way, Decatur, 30030, GA, USA.ORCID 0000-0002-4120-4398
Reza Niles-RobinNeglected Tropical Disease Program, Vector Control Services, Ministry of Health, Georgetown, Guyana.ORCID 0000-0001-5948-4335
Annastacia SampsonNeglected Tropical Disease Program, Vector Control Services, Ministry of Health, Georgetown, Guyana.
Ana MoriceNeglected, Tropical, and Vector-Borne Diseases Unit, Communicable Diseases and Environmental Determinants of Health Department, Pan American Health Organization, Washington, 20037, DC, USA.
Ronaldo Carvalho ScholteNeglected, Tropical, and Vector-Borne Diseases Unit, Communicable Diseases and Environmental Determinants of Health Department, Pan American Health Organization, Washington, 20037, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current WHO guidelines set prevalence thresholds below which a neglected tropical disease can be considered to have been eliminated as a public health problem, and specify how surveys to assess whether elimination has been achieved should be designed and analysed, based on classical survey sampling methods. In this paper, we describe an alternative approach based on geospatial statistical modelling. We first show the gains in efficiency that can be obtained by exploiting any spatial correlation in the underlying prevalence. We then suggest that the current guidelines' implicit use of a significance testing argument is not appropriate; instead, we argue for a predictive inferential framework, leading to design criteria based on controlling the rates at which areas whose true prevalence lies above and below the elimination threshold are incorrectly classified. We describe how this approach naturally accommodates context-specific information in the form of georeferenced covariates that have been shown to be predictive of disease prevalence. Finally, we give a progress report of an ongoing collaboration with the Guyana Ministry of Health Neglected Tropical Disease programme on the design of an IDA (ivermectin, diethylcarbamazine and albendazole) Impact Survey of lymphatic filariasis to be conducted in Guyana in early 2023. This article is part of the theme issue 'Challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs'.

Indexed as

AlbendazoleDiethylcarbamazineHumansIvermectinLondonNeglected DiseasesPrevalenceAlbendazoleDiethylcarbamazineIvermectingeospatial methodsNTDprevalence survey

Identifiers

PMID37598704
PMCPMC10440170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.